Is Rapid Micro Biosystems Inc (RPID) overvalued? · rev $28.1M
Rapid Micro Biosystems Inc (RPID) is a medical devices company listed on NASDAQ.
This page asks whether Rapid Micro Biosystems Inc (RPID) looks expensive on cached numbers — not a short thesis.
Latest reported RPID revenue for 2024-12-31 was $28.1M. Net income was -$46.9M. Revenue was up 24.6% from 2023-12-31 to 2024-12-31. RPID currently screens at market cap $85.7M.
RPID currently screens at market cap $85.7M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next RPID 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the RPID stock page for the full model, not this heading.
Not investment advice.